Latham & Watkins

Latham & Watkins maintains a comprehensive healthcare and life sciences practice spanning corporate transactions, commercial arrangements, regulatory advisory work, and litigation. The firm advises on M&A and capital markets transactions, as well as strategic alliances and joint ventures, alongside regulatory matters involving government approvals and oversight and disputes ranging from IP litigation to white-collar investigations and defense. Leadership of the practice includes Shayne Kennedy, global healthcare and life sciences industry chair, who advises on public and private securities offerings for issuers and underwriters in biotechnology, medical devices, pharmaceuticals, and healthcare from California, and John Manthei, global healthcare and life sciences practice chair, who regularly counsels clients across the medical device, pharmaceutical, biotechnology, and dietary supplement industries from Washington, DC. Arlene Lee Chow and Terra Reynolds also serve as global healthcare and life sciences industry chairs, working from New York and Chicago respectively. In Washington, DC, regulatory depth is reflected in the work of Ben Haas and William A. McConagha on FDA-related matters across the product lifecycle, while Elizabeth M. Richards focuses on FDA regulatory strategy, compliance, enforcement, and technology-driven life sciences matters. Peter N. Handrinos covers life sciences M&A and public offerings, working from Boston and New York, and Julie Scallen and Cheston Larson advise on corporate transactions from Boston and San Diego respectively. Kate Hillier bolsters the team's expertise from Silicon Valley as a 'brilliant, creative, business savvy, and fabulous' partner.